GLP-1RAs and Isotretinoin: A Risky Combination
Weight loss: the slowest but most visible outcome Weight loss is the outcome everyone focuses on, but it is the slowest to manifest in meaningful amounts
It is important that you follow the titration schedule to prevent any complications
10.1002/iid3.1168 44 FuB.YangJ.ChenJ.LinL.ChenK.ZhangW.et al (2019)
Across corticosteroids, acetaminophen, NSAIDs, and opioids, a consistent pattern emerges: Inflammation is suppressed, but tissue repair is impaired Pain signals are blocked, but nervous system sensitivity increases Symptoms are quieted, but root causes remain unaddressed Over time, this creates a widening gap between temporary symptom relief and true physiologic recovery
The OASIS 4 trial, organized by drugmaker Novo Nordisk, showed that after taking the pill for 64 weeks, participants lost an average of 13.6 percent of their body weight